We are pleased to share that BrightInsight co-founder and CEO, Kal Patel, MD, has been named a Top 50 Healthcare Technology CEO by Technology Innovators Magazine. Kal is joined on the list by other luminaries of digital health including Anne Wojcicki of 23andMe, Ido Shoenberg of Amwell, Leo Grady of Paige and Hill Ferguson of Doctor on Demand, among many others. You can read the feature on Kal here and see the entire list here.
As the editors of Technology Innovators explain, the pandemic has accelerated healthcare’s digital transformation and adoption. The explosive growth in telehealth and the continued pursuit of precision medicine is driving adoption of emerging new technologies including digital to improve patient outcomes.
The current market dynamics are helping to fuel adoption of our BrightInsight Platform. In 2020, during the uncertainty of the pandemic, Kal notes that one of the major achievements of our company was securing a Series B round of financing. We quickly followed up with our Series C round of $101M led by General Catalyst in early 2021. In both cases, our investors understood the value proposition of BrightInsight—providing a global platform for biopharma and medtech to accelerate time to market for their digital health apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device—all meeting regulatory, security, privacy and quality requirements around the world.
Many of the world’s leading biopharma and medtech companies have partnered with BrightInsight including CSL Behring, Novo Nordisk, Roche and AstraZeneca. Earlier this year, we announced the launch of the AMAZE Disease Management Platform from AstraZeneca, built on our BrightInsight Platform. The AMAZE Platform, went from kick off to launch with Mass General Hospital in just 12 months.
We are thrilled by this recognition of Kal and his unwavering leadership during BrightInsight’s hyper-growth!